Meningiomas are the most common primary intracranial tumor. Important advances are
occurring in meningioma research. These are expected to accelerate, potentially leading to …

Meningiomas are the most common primary intracranial tumors. The majority of
meningiomas are benign, but they can present different grades of dedifferentiation from …

Meningiomas are the most frequent nonglial primary brain tumors and represent about 30%
of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging …

The archetypal imaging characteristics of meningiomas are among the most stereotypic of
all central nervous system (CNS) tumors. In the era of plain film and ventriculography …

Surgery has long been established as the first-line treatment for the majority of symptomatic
and enlarging meningiomas, and evidence for its success is derived from retrospective case …

Purpose Meningiomas are the most frequently diagnosed intracranial neoplasms. Usually,
they are treated by surgical resection in curative intent. Radiotherapy and stereotactic …

Somatostatin receptor (SSTR)–targeted peptide receptor radionuclide therapy (PRRT)
represents a promising approach for treatment-refractory meningiomas. Methods: We …

Background The prognosis of patients with progressive meningioma after failure of surgery
and radiotherapy is poor. Methods We retrospectively evaluated the safety and efficacy of …

Simple Summary Positron emission tomography (PET) imaging is increasingly used to
supplement MRI in the management of patient with brain tumors. In this article, we provide a …

Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled
receptor and can be activated by somatostatin or its synthetic analogs. SSTR2 is therefore …